KYG2588M1006
KYG2588M1006
CSTONE PHARMA-B
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 269.583.000 | 407.205.000 | 33.8% |
| Cost of Revenue | 218.336.000 | 167.051.000 | 30.7% |
| Gross Profit | 51.247.000 | 240.154.000 | 78.7% |
| 468.742.000 | 331.846.000 | 41.3% | |
| Operating Income | -417.495.000 | -91.692.000 | 355.3% |
| Pretax Income | -423.939.000 | -91.207.000 | 364.8% |
| Net Income Common Stockholders | -437.003.000 | -91.207.000 | 379.1% |
| -- | -- | -- | |
| -- | -- | -- |